Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-23

Clinical Trial Update: Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating familial fecal microbiota transplant for autism spectrum disorders; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Familial fecal microbiota transplant (fecal microbiota transplant)

Snippet

Sponsor: ProgenaBiome | Conditions: Autism, Autism Spectrum Disorder | Phase 1 | Status: NOT_YET_RECRUITING